PARP Inhibitors in Cancer Diagnosis and Therapy. (2021)
Attributed to:
Imaging DNA damage repair during radionuclide therapy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-20-2766
PubMed Identifier: 33082213
Publication URI: http://europepmc.org/abstract/MED/33082213
Type: Journal Article/Review
Volume: 27
Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research
Issue: 6
ISSN: 1078-0432